Concepedia

Nerissa Mendoza

NM

Statistics

Publications

9

Citations

830

H-Index

9

Active since

2002

Affiliations

Molecular Oncology (United States)(Current)

XOMA (United States)

Nerissa Mendoza is an author at Molecular Oncology (United States) specializing in medicine, oncogenic signaling pathways, and cell signaling.

ORCID

Publications per year

2002–2016

9

Publications

9

Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer

Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha et al. · Cancer Research · 2006 · 483 citations

, , +17

Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.

Nerissa Mendoza, Gail D. Lewis Phillips, Johnny Silva et al. · PubMed · 2002 · 79 citations

, , +16

Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor XIa

Mark Peek, Paul Moran, Nerissa Mendoza et al. · Journal of Biological Chemistry · 2002 · 70 citations · Full text

, , +11

Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.

Nerissa Mendoza, Sharon Fong, Jim Marsters et al. · PubMed · 2003 · 69 citations

, , +17

Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium

Kathleen C. Flanders, Yu-an Yang, Michelle A. Herrmann et al. · Oncotarget · 2016 · 45 citations · Full text

, , +12

1–5 of 9